Puma Biotechnology, Inc. (PBYI)

Last Closing Price: 4.97 (2025-08-28)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Puma Biotechnology, Inc. (PBYI) had Net Income of $5.86M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$52.44M
Net Income
$5.86M
$12.30M
$40.13M
$45.80M
$6.64M
$-0.47M
$6.17M
$6.17M
$5.86M
$5.86M
$5.86M
$5.86M
$6.64M
$9.40M
49.70M
50.15M
$0.12
$0.12
Balance Sheet Financials
$136.58M
$0.39M
$58.34M
$194.92M
$79.10M
$10.87M
$11.10M
$90.20M
$104.72M
$58.46M
$104.72M
49.89M
Cash Flow Statement Financials
$17.69M
$-9.72M
$-22.53M
$71.31M
$56.75M
$-14.56M
$3.65M
--
--
Fundamental Metrics & Ratios
1.73
--
--
0.09
0.43
76.54%
12.66%
12.66%
--
11.76%
11.17%
$17.61M
--
--
--
0.27
1.43
2.02
44.47
5.59%
10.02%
3.00%
5.07%
$2.10
$0.35
$0.35